R1 RCM Inc. (NASDAQ:RCM) Given Average Recommendation of "Hold" by Brokerages

Shares of R1 RCM Inc. (NASDAQ:RCM - Get Free Report) have been given an average rating of "Hold" by the eighteen research firms that are presently covering the company, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $15.41.

RCM has been the topic of a number of research reports. Cantor Fitzgerald reissued a "neutral" rating and set a $14.30 target price on shares of R1 RCM in a research report on Friday, October 4th. Stephens cut shares of R1 RCM from an "overweight" rating to an "equal weight" rating in a research note on Thursday, August 1st. Leerink Partners cut shares of R1 RCM from an "outperform" rating to a "market perform" rating and lowered their target price for the stock from $17.00 to $14.30 in a research note on Thursday, August 1st. TD Cowen reiterated a "hold" rating and issued a $14.30 target price (down from $20.00) on shares of R1 RCM in a research note on Monday, August 5th. Finally, Truist Financial lowered their target price on shares of R1 RCM from $16.00 to $14.30 and set a "hold" rating for the company in a research note on Thursday, August 8th.

Hedge Funds Weigh In On R1 RCM

Institutional investors have recently made changes to their positions in the company. Barclays PLC increased its holdings in R1 RCM by 41.5% in the 3rd quarter. Barclays PLC now owns 74,156 shares of the healthcare provider's stock worth $1,051,000 after acquiring an additional 21,754 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in R1 RCM by 42.1% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 84,968 shares of the healthcare provider's stock worth $1,204,000 after acquiring an additional 25,163 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in R1 RCM in the 3rd quarter worth $446,000. EP Wealth Advisors LLC purchased a new stake in shares of R1 RCM during the third quarter worth $168,000. Finally, Murchinson Ltd. purchased a new stake in shares of R1 RCM during the third quarter worth $184,000. 61.10% of the stock is owned by hedge funds and other institutional investors.

R1 RCM Price Performance

RCM stock remained flat at $14.31 during trading on Thursday. The stock has a market capitalization of $6.04 billion, a P/E ratio of -95.39 and a beta of 0.84. R1 RCM has a 12-month low of $8.87 and a 12-month high of $15.12. The stock has a 50 day moving average price of $14.23 and a 200 day moving average price of $13.45. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.76.

R1 RCM (NASDAQ:RCM - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.04). The company had revenue of $656.80 million during the quarter, compared to analysts' expectations of $640.93 million. R1 RCM had a negative return on equity of 2.18% and a negative net margin of 2.48%. The firm's revenue was up 14.7% on a year-over-year basis. As a group, research analysts predict that R1 RCM will post -0.18 earnings per share for the current fiscal year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.